Imaging in Oncology 2vols

Part I: General Principles 1. An Overview of Imaging in Oncology 2. Trends in
Cancer Incidence, Survival and Mortality 3. Staging of Cancer 4. Part 1:
Multidisciplinary Treatment of Cancer: Part 2: Chemotherapy Part 3:
Radiotherapy 5. Assessment of Response to Treatment 6. Second Malignancies Part
II: Primary Tumour Evaluation and Staging 7. Lung Cancer 8. Mediastinal Tumours
9. Pleural Tumours 10. Oesophageal Cancer 11. Gastric Cancer 12. Colorectal
Cancer 13. Primary Tumours of the Liver and Biliary Tract 14. Renal Tumours 15.
Primary Adrenal Malignancy 16. Pancreatic Malignancy 17. Bladder Cancer 18.
Prostate Cancer 19. Testicular Germ Cell Tumours 20. Ovarian Cancer 21. Uterine
and Cervical Tumours 22. Primary Retroperitoneal Tumours 23. Primary Bone
Tumours 24. Soft Tissue Sarcomas 25. Breast Cancer 26. Paranasal Sinus
Neoplasms 27. Tumours of the Pharynx, Tongue and Mouth 28. Laryngeal Tumours
29. Thyroid Cancer 30. Primary Tumours of the Central Nervous System 31.
Neuroendocrine Tumours Part III: Haematological Malignancy 32. Lymphoma 33.
Multiple Myeloma 34. Leukaemia Part IV: Paediatrics 35. General Principles in
Paediatric Oncology 36. Wilms' Tumour and Associated Neoplasms of the Kidney
37. Neuroblastoma 38. Uncommon Paediatric Neoplasms Part V: Metastases 39.
Lymph Node Metastases 40. Lung and Pleural Metastases 41. Bone Metastases 42.
The Liver 43. Metastatic Effects on the Nervous System 44. Adrenal Metastases
45. Peritoneal Metastases 46. Spleen 47. Malignant Tumours of the Skin 48.
Radiological Investigation of Carcinoma of Unknown Primary Site Part VI:
Imaging and Treatment 49. Interventional Imaging: General Applications 50.
Interventional Imaging: Tumour Ablation 51. Imaging for Radiotherapy Treatment
Planning 52. Radiological Manifestations of Acute Complications of Treatment
Part VII: Effects of Treatment on Normal Tissue 53. Effects of Treatment on
Normal Tissue: Thorax 54. Effects of Treatment: Bone and Bone Marrow 55.
Abdomen and Pelvis Part VIII: The Immunocompromised Host 56. The
Immunocompromised Host: Clinical Considerations 57. The Immunocompromised Host:
Central Nervous System 58. The Immunocompromised Host: Chest 59. The
Immunocompromised Host: Abdomen and Pelvis Part IX: New Horizons in Imaging 60.
MR Lymphography 61. Imaging Angiogenesis: Clinical Implications 62. Molecular
Imaging in Cancer Treatment: PET 63. Molecular Imaging in Cancer Treatment: MRI


Product Note:
SPECIAL OFFER PRICE UNTIL MAY 31st 2004 - ?50. Usual Price ?95


Full Contributors:
Suzanne L Aquino, MD, Massachusetts General Hospital, Boston, USA
Peter Armstrong, St Bartholomew's Hospital, London, UK
Syed Babar, St Bartholomew's Hospital, London, UK
Jelle Barentsz, University Hospital Nijmegen, The Netherlands
Richard L Baron, MD, University of Chicago, USA
Ann Barrett, MD, FRCR, FRCP, FMed, University of East Anglia, Norwich, UK
Jonathon Berlin, University of East Anglia, Norwich, UK
Juliet Britton, Atkinson Morley's Hospital, Wimbledon, UK
Keith E Britton, MD, MSc, FRCR, FRCP, Queen Mary Hospital and St Bartholomew's
Hospital, London, UK
Gina Brown, Royal Marsden Hospital, Sutton, UK
Guy J C Burkill, BSc, MBBS, MRCP, FRCR, The Royal Sussex County Hospital, UK
Bernadette M Carrington, Christie Hospital NHS Trust, Manchester, UK
Helen Carty, Royal Liverpool Children's NHS Trust, Alder Hey, Liverpool, UK
Paul Caruso, MD, Harvard Medical School, Boston, USA
Richard H Cohab, MD, University of Michigan Hospital, Ann Arbor, USA
Michel P Coleman, BA, BM, BCh, MSc, FPHM, London School of Hygiene & Tropical
Medicine, UK
Conor D Collins, St Vincent's University Hospital, Elm Park, Ireland
Gary Cook, St Vincent's University Hospital, Elm Park, Ireland
Hugh Curtin, Massachusetts Eye and Ear Infirmary, Boston, USA
Sujal R Desai, King's College Hospital, London, UK
W Deserno, St Vincent's University Hospital, Elm Park, Ireland
H Jane Dobb